View in EDS

Sex differences in the efficacy, safety and persistence of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of phase III and long-term extension trials.

Saved in:
Bibliographic Details
Title: Sex differences in the efficacy, safety and persistence of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of phase III and long-term extension trials.
Authors: Strand V; Division of Immunology/Rheumatology, Stanford University, Palo Alto, California, USA., Schulze-Koops H; Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, University of Munich, Munich, Germany., Al-Emadi S; Hamad Medical Corporation, Doha, Qatar., Kinch CD; Pfizer Canada ULC, Kirkland, Quebec, Canada kinch.cassandra.d@gmail.com., Gruben D; Pfizer Inc, Groton, Connecticut, USA., Germino R; Pfizer Inc, New York, New York, USA., Connell CA; Pfizer Inc, Groton, Connecticut, USA., Mysler E; Rheumatology, Organización Médica de Investigación, Buenos Aires, Argentina.
Source: BMJ open [BMJ Open] 2025 Dec 24; Vol. 15 (12), pp. e082366. Date of Electronic Publication: 2025 Dec 24.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41448717
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Sex differences in the efficacy, safety and persistence of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of phase III and long-term extension trials.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Strand+V%22">Strand V</searchLink>; Division of Immunology/Rheumatology, Stanford University, Palo Alto, California, USA.<br /><searchLink fieldCode="AU" term="%22Schulze-Koops+H%22">Schulze-Koops H</searchLink>; Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, University of Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Al-Emadi+S%22">Al-Emadi S</searchLink>; Hamad Medical Corporation, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Kinch+CD%22">Kinch CD</searchLink>; Pfizer Canada ULC, Kirkland, Quebec, Canada kinch.cassandra.d@gmail.com.<br /><searchLink fieldCode="AU" term="%22Gruben+D%22">Gruben D</searchLink>; Pfizer Inc, Groton, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Germino+R%22">Germino R</searchLink>; Pfizer Inc, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Connell+CA%22">Connell CA</searchLink>; Pfizer Inc, Groton, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Mysler+E%22">Mysler E</searchLink>; Rheumatology, Organización Médica de Investigación, Buenos Aires, Argentina.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101552874%22">BMJ open</searchLink> [BMJ Open] 2025 Dec 24; Vol. 15 (12), pp. e082366. <i>Date of Electronic Publication: </i>2025 Dec 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101552874 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-6055 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220446055%22">20446055 </searchLink><i>NLM ISO Abbreviation: </i>BMJ Open <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41448717
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/bmjopen-2023-082366
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e082366
    Titles:
      – TitleFull: Sex differences in the efficacy, safety and persistence of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of phase III and long-term extension trials.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Strand V
      – PersonEntity:
          Name:
            NameFull: Schulze-Koops H
      – PersonEntity:
          Name:
            NameFull: Al-Emadi S
      – PersonEntity:
          Name:
            NameFull: Kinch CD
      – PersonEntity:
          Name:
            NameFull: Gruben D
      – PersonEntity:
          Name:
            NameFull: Germino R
      – PersonEntity:
          Name:
            NameFull: Connell CA
      – PersonEntity:
          Name:
            NameFull: Mysler E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 12
              Text: 2025 Dec 24
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2044-6055
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: BMJ open
              Type: main
ResultId 1